CoChat

A Novel Fluorescent Reporter System Identifies Laminin-511/521 as Potent Regulators of Cardiomyocyte Maturation

Open access

The DOI matches its Crossref record; 53 of the 55 references it cites were found in a registry or an index.

Abstract

Pluripotent stem cell-derived cardiomyocytes (PSC-CMs) hold great promise for disease modeling and drug discovery. However, PSC-CMs exhibit immature phenotypes in culture, and the lack of maturity limits their broad applications. While physical and functional analyses are generally used to determine the status of cardiomyocyte maturation, they could be time-consuming and often present challenges in comparing maturation-enhancing strategies. Therefore, there is a demand for a method to assess cardiomyocyte maturation rapidly and reproducibly. In this study, we found that Myomesin-2 (Myom2), encoding M-protein, is upregulated postnatally, and based on this, we targeted TagRFP to the Myom2 locus in mouse embryonic stem cells. Myom2-RFP+ PSC-CMs exhibited more mature phenotypes than RFP- cells in morphology, function and transcriptionally, conductive to sarcomere shortening assays. Using this system, we screened extracellular matrices (ECMs) and identified laminin-511/521 as potent enhancers of cardiomyocyte maturation. Together, we developed and characterized a novel fluorescent reporter system for the assessment of cardiomyocyte maturation and identified potent maturation-enhancing ECMs through this simple and rapid assay. This system is expected to facilitate use of PSC-CMs in a variety of scientific and medical investigations.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-020-61163-3

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 CRISPR/Cas9-mediated knock-in of TagRFP into Myom2. (a) Myom2 expression during heart development (from embryonic day (E) 11 to postnatal day (P) 56). 3′ mRNA-seq results are shown as transcripts per million reads. A blue line indicates local regression curve using locally estimated scatterplot smoothing (LOESS). (b) A scheme showing localizations of Myom2 in M-line, α-actinin in Z-line, and cardiac troponin T (cTnT) in actin thin filaments of sarcomere structure. (c) Representative images of Myom2 expression and localization in different stages of heart development including E16.5, P4, and adult heart; Myom2 (red), α-actinin (green), and DAPI for nuclei (blue). Higher magnification images are shown in insets. Scale bar, 20 μm. (d) A schematic overview of (i) wild-type Myom2 locus, (ii) Myom2-RFP/Blast targeting construct, knocked-in Myom2-RFP (iii) with and (iv) without a blasticidin-resistance cassette, and forward and reverse primer binding sites for testing knock-in. (e) PCR screen to identify correct targeted clones: 3′ end screen of integration of TagRFP in subclones SMM2, 18, 19, and 23 (Top panel). Confirmation of deletion of the blasticidin-resistance cassette in subclones SMMB1, 2, 5, 6, and 7 (Bottom panels, both left and right).
Figure 1 CRISPR/Cas9-mediated knock-in of TagRFP into Myom2. (a) Myom2 expression during heart development (from embryonic day (E) 11 to postnatal day (P) 56). 3′ mRNA-seq results are shown as transcripts per million reads. A blue line indicates local regression curve using locally estimated scatterplot smoothing (LOESS). (b) A scheme showing localizations of Myom2 in M-line, α-actinin in Z-line, and cardiac troponin T (cTnT) in actin thin filaments of sarcomere structure. (c) Representative images of Myom2 expression and localization in different stages of heart development including E16.5, P4, and adult heart; Myom2 (red), α-actinin (green), and DAPI for nuclei (blue). Higher magnification images are shown in insets. Scale bar, 20 μm. (d) A schematic overview of (i) wild-type Myom2 locus, (ii) Myom2-RFP/Blast targeting construct, knocked-in Myom2-RFP (iii) with and (iv) without a blasticidin-resistance cassette, and forward and reverse primer binding sites for testing knock-in. (e) PCR screen to identify correct targeted clones: 3′ end screen of integration of TagRFP in subclones SMM2, 18, 19, and 23 (Top panel). Confirmation of deletion of the blasticidin-resistance cassette in subclones SMMB1, 2, 5, 6, and 7 (Bottom panels, both left and right).CC BY · PubMed Central
Figure 2 Characterizations of the Myom2-RFP ESC line as a cardiomyocyte maturation reporter. (a) A schematic protocol for cardiac differentiation. (b) Myom2-RFP expression during a prolonged culture. Data is presented as means ± SD (n = 4). One-way ANOVA with post-hoc Tukey HSD test; § P < 0.01, † P < 0.0001. Fluorescence intensity is presented as arbitrary unit (a.u.). (c) Representative fluorescence images of RFP− and RFP+ cardiomyocytes at day 28. A yellow line indicates the line scan region displayed in (d). Myom2-RFP (red); α-actinin (green); Nuclei (blue). Scale bar, 20 μm. (d) Corresponding line scan for the altered pattern of Myom2-RFP and α-actinin in a sarcomere. (e) Comparisons of structure and morphology between RFP− and RFP+ cardiomyocytes (n > 65). Sarcomere length, cell area, perimeter length, cell length, cell width, and aspect ratio were examined. For violin plots, black lines in the white boxes show the medians, box limits indicate the 25th and 75th percentiles, whiskers extend 1.5 times the interquartile range from the 25th and 75th percentiles, and polygons represent density estimates of data and extend to extreme values. Student’s t test; *P < 0.05, §P < 0.01, #P < 0.001, †P < 0.0001. (f) Proportion of mononuclear and binuclear cells in RFP+ and RFP− PSC-CMs at day 21 and 28 (n > 65). Chi-square Test; #P < 0.001, †P < 0.0001. (g–i) Calcium transients of RFP− and RFP+ cardiomyocytes: (g) Representative time-lapse images of calcium transients for RFP− and RFP+ cardiomyocytes (scale bar, 20 μm), and (h) corresponding spatially averaged profiles of cytosolic calcium transients evoked by electrical field stimulation at 1 Hz, at day 28. (i) Mean values of time to peak, peak amplitude, and decay time of Ca2+ transients (n > 30). Student’s t test; #P < 0.001, †P < 0.0001. (j–m) Sarcomere shortening assays for PSC-CMs using Myom2-RFP: (j) Representative images for sarcomere shortening with measuring regions as indicated by yellow bars and (k) corresponding line scans of sarcomere lengths. (l) Sarcomere shortening profile of RFP+ cardiomyocytes. (m) Normalized sarcomere lengths and percent of sarcomere shortening of RFP+ cardiomyocytes (n = 38).
Figure 2 Characterizations of the Myom2-RFP ESC line as a cardiomyocyte maturation reporter. (a) A schematic protocol for cardiac differentiation. (b) Myom2-RFP expression during a prolonged culture. Data is presented as means ± SD (n = 4). One-way ANOVA with post-hoc Tukey HSD test; § P < 0.01, † P < 0.0001. Fluorescence intensity is presented as arbitrary unit (a.u.). (c) Representative fluorescence images of RFP− and RFP+ cardiomyocytes at day 28. A yellow line indicates the line scan region displayed in (d). Myom2-RFP (red); α-actinin (green); Nuclei (blue). Scale bar, 20 μm. (d) Corresponding line scan for the altered pattern of Myom2-RFP and α-actinin in a sarcomere. (e) Comparisons of structure and morphology between RFP− and RFP+ cardiomyocytes (n > 65). Sarcomere length, cell area, perimeter length, cell length, cell width, and aspect ratio were examined. For violin plots, black lines in the white boxes show the medians, box limits indicate the 25th and 75th percentiles, whiskers extend 1.5 times the interquartile range from the 25th and 75th percentiles, and polygons represent density estimates of data and extend to extreme values. Student’s t test; *P < 0.05, §P < 0.01, #P < 0.001, †P < 0.0001. (f) Proportion of mononuclear and binuclear cells in RFP+ and RFP− PSC-CMs at day 21 and 28 (n > 65). Chi-square Test; #P < 0.001, †P < 0.0001. (g–i) Calcium transients of RFP− and RFP+ cardiomyocytes: (g) Representative time-lapse images of calcium transients for RFP− and RFP+ cardiomyocytes (scale bar, 20 μm), and (h) corresponding spatially averaged profiles of cytosolic calcium transients evoked by electrical field stimulation at 1 Hz, at day 28. (i) Mean values of time to peak, peak amplitude, and decay time of Ca2+ transients (n > 30). Student’s t test; #P < 0.001, †P < 0.0001. (j–m) Sarcomere shortening assays for PSC-CMs using Myom2-RFP: (j) Representative images for sarcomere shortening with measuring regions as indicated by yellow bars and (k) corresponding line scans of sarcomere lengths. (l) Sarcomere shortening profile of RFP+ cardiomyocytes. (m) Normalized sarcomere lengths and percent of sarcomere shortening of RFP+ cardiomyocytes (n = 38).CC BY · PubMed Central
Figure 3 Transcriptome analysis of RFP+ and RFP− cardiomyocytes. (a) A heatmap of upregulated genes in RFP+ PSC-CMs at days 17 and 24 compared to RFP− cells. Rlog values are coded on the red-to-blue scale (higher expression, red; lower expression, blue). (b) Expressions of Myom2 in PSC-CMs at different time points (day 10, 17, 24, and 38). (c) Correlation between Myom2 expressions and RFP intensities in RFP+ PSC-CMs from day 17 to day 38. The correlation coefficient (R2) between Myom2 expression levels and RFP intensities was 0.916. (d) GO terms for molecular function identify for differentially enriched genes in RFP+ and RFP− cardiomyocytes. The x-axis represents the logarithms of the adjusted P-value. (e) Averaged gene expression of 8 selected GO terms for biological processes.
Figure 3 Transcriptome analysis of RFP+ and RFP− cardiomyocytes. (a) A heatmap of upregulated genes in RFP+ PSC-CMs at days 17 and 24 compared to RFP− cells. Rlog values are coded on the red-to-blue scale (higher expression, red; lower expression, blue). (b) Expressions of Myom2 in PSC-CMs at different time points (day 10, 17, 24, and 38). (c) Correlation between Myom2 expressions and RFP intensities in RFP+ PSC-CMs from day 17 to day 38. The correlation coefficient (R2) between Myom2 expression levels and RFP intensities was 0.916. (d) GO terms for molecular function identify for differentially enriched genes in RFP+ and RFP− cardiomyocytes. The x-axis represents the logarithms of the adjusted P-value. (e) Averaged gene expression of 8 selected GO terms for biological processes.CC BY · PubMed Central
Figure 4 ECMs increased RFP intensity and led to structural maturation. (a) Expression profiles of selected ECMs including laminin, collagen, and fibronectin during heart development (E11 to P56). (b) A schematic diagram of the experiment for quantification of Myom2-RFP expression and structural analysis after ECM treatments for 38 days of cardiac differentiation. (c) Effects of ECM treatments on fraction of RFP+ cardiomyocytes and RFP intensity. Data are presented as means ± SD (n = 3). Fluorescence intensities are presented as arbitrary unit (a.u.). Dunnett’s test was used to compare each ECM treatment with a control (gelatin); *P < 0.05, §P < 0.01, #P < 0.001, †P < 0.0001. (d) Representative images for ECM-treated cells stained with α-actinin antibody (green), TagRFP (red), and DAPI for nuclei (blue). Scale bar, 20 μm. (e) Statistics of structural and morphological features. Sarcomere length, cell area, cell length, and cell width were examined. To note, ECM-treated cells exhibited significant increase in sarcomere length, cell area, cell length, and cell width, especially with laminin (LN)-511/521 treatments, compared with controls. Violin plots are explained in Fig. 2. n > 100 from three different cardiac differentiation runs. Dunnett’s test was used to compare each ECM treatment with a control (gelatin); *P < 0.05, §P < 0.01, #P < 0.001, †P < 0.0001.
Figure 4 ECMs increased RFP intensity and led to structural maturation. (a) Expression profiles of selected ECMs including laminin, collagen, and fibronectin during heart development (E11 to P56). (b) A schematic diagram of the experiment for quantification of Myom2-RFP expression and structural analysis after ECM treatments for 38 days of cardiac differentiation. (c) Effects of ECM treatments on fraction of RFP+ cardiomyocytes and RFP intensity. Data are presented as means ± SD (n = 3). Fluorescence intensities are presented as arbitrary unit (a.u.). Dunnett’s test was used to compare each ECM treatment with a control (gelatin); *P < 0.05, §P < 0.01, #P < 0.001, †P < 0.0001. (d) Representative images for ECM-treated cells stained with α-actinin antibody (green), TagRFP (red), and DAPI for nuclei (blue). Scale bar, 20 μm. (e) Statistics of structural and morphological features. Sarcomere length, cell area, cell length, and cell width were examined. To note, ECM-treated cells exhibited significant increase in sarcomere length, cell area, cell length, and cell width, especially with laminin (LN)-511/521 treatments, compared with controls. Violin plots are explained in Fig. 2. n > 100 from three different cardiac differentiation runs. Dunnett’s test was used to compare each ECM treatment with a control (gelatin); *P < 0.05, §P < 0.01, #P < 0.001, †P < 0.0001.CC BY · PubMed Central
Figure 5 Functional and transcriptional analysis after laminin-511/521 treatments. (a) Proportions of mononuclear and binuclear cells in PSC-CMs cultured on laminin-511/521 compared to gelatin (n > 100). (b) Representative images of PSC-CMs stained for Cx43 at day 38 of differentiation. Scale bar, 20 μm. (c) Representative traces for PSC-CMs on laminin-511/521 and gelatin responding to oligomycin, FCCP, and rotenone/antimycin A. (d) Statistical analyses of OCRs for (i) Basal respiration, (ii) ATP-linked respiration, (iii) proton leak, and (iv) maximal respiration. Data are presented as means ± SD (n = 3). Dunnett’s test was used to compare PSC-CMs on laminin with ones on gelatin as a control; *P < 0.05, §P < 0.01, #P < 0.001, †P < 0.0001. (e) Representative intracellular calcium transients from PSC-CMs on gelatin and laminin-511/521, stimulated at 1 Hz, at day 38. (f) Mean values of time to peak, peak amplitude, and decay time of Ca2+ transients (n > 80). Dunnett’s test; *P < 0.05, †P < 0.0001. (g) Representative traces showing sarcomere length during electric-pulse stimulation (1 Hz). (h) Averaged data of sarcomere shortening. Data are presented as means ± SD (n > 40). Dunnett’s test; *P < 0.05, §P < 0.01. (i) Averaged gene expression of 8 selected GO terms for biological processes. (j) Compared to gelatin, known genes related to the development of cardiomyocytes were upregulated in PSC-CMs on laminin-511/521 such as cardiac marker genes (Tnnt2 and Actc1), a transcription factor gene for cardiac gene expression (Ankrd23), a calcium handling gene (Casq2), and sarcomere genes (Mybpc2, Mybpc3, Myh7, and Myl2).
Figure 5 Functional and transcriptional analysis after laminin-511/521 treatments. (a) Proportions of mononuclear and binuclear cells in PSC-CMs cultured on laminin-511/521 compared to gelatin (n > 100). (b) Representative images of PSC-CMs stained for Cx43 at day 38 of differentiation. Scale bar, 20 μm. (c) Representative traces for PSC-CMs on laminin-511/521 and gelatin responding to oligomycin, FCCP, and rotenone/antimycin A. (d) Statistical analyses of OCRs for (i) Basal respiration, (ii) ATP-linked respiration, (iii) proton leak, and (iv) maximal respiration. Data are presented as means ± SD (n = 3). Dunnett’s test was used to compare PSC-CMs on laminin with ones on gelatin as a control; *P < 0.05, §P < 0.01, #P < 0.001, †P < 0.0001. (e) Representative intracellular calcium transients from PSC-CMs on gelatin and laminin-511/521, stimulated at 1 Hz, at day 38. (f) Mean values of time to peak, peak amplitude, and decay time of Ca2+ transients (n > 80). Dunnett’s test; *P < 0.05, †P < 0.0001. (g) Representative traces showing sarcomere length during electric-pulse stimulation (1 Hz). (h) Averaged data of sarcomere shortening. Data are presented as means ± SD (n > 40). Dunnett’s test; *P < 0.05, §P < 0.01. (i) Averaged gene expression of 8 selected GO terms for biological processes. (j) Compared to gelatin, known genes related to the development of cardiomyocytes were upregulated in PSC-CMs on laminin-511/521 such as cardiac marker genes (Tnnt2 and Actc1), a transcription factor gene for cardiac gene expression (Ankrd23), a calcium handling gene (Casq2), and sarcomere genes (Mybpc2, Mybpc3, Myh7, and Myl2).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 53 references

Research works printed but not linked: 1

  1. Soonpaa, M. H. et al. synthesis and binucleation during murine development. Am. J. Physiol. 271, H2183–2189 (1996).

Cited by

See all 38

Metadata

Authors
Chanthra, N., Abe, T., Miyamoto, M., Sekiguchi, K., Kwon, C., Hanazono, Y., & Uosaki, H.
Affiliations
  • Jichi Medical University (JP)
  • Johns Hopkins University (US)
  • Institute for Protein Research, The University of Osaka (JP)
Corresponding author
Uosaki, Hideki
Venue
Scientific Reports
Published
2020-03-06
Volume
10
Issue
1
Pages
4249-4249
ISSN
2045-2322 (ISSN-L)
OpenAlex
W3010490804
Cited by
36
References
55
Citations by year
2026: 4 · 2025: 8 · 2024: 3 · 2023: 4 · 2022: 6 · 2021: 8 · 2020: 3
FWCI
1.70
Type
journal article
Language
en
Open access
Licence
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • Jichi Medical University
  • Japan Agency for Medical Research and Development (17bm0404005h0005, 18bm0704012h0003)
  • Japan Society for the Promotion of Science (19K17613)
  • Novartis Research Grant
  • Japan Research Promotion Society for Cardiovascular Diseases
  • Takeda Science Foundation
  • The Uehara Memorial Foundation
  • SENSHIN Medical Research Foundation
  • the Japanese Circulation Society
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Congenital heart defects research
  • Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
Keywords
cardiomyocyte maturation, fluorescent reporter system, TagRFP, pluripotent stem cell-derived cardiomyocytes, extracellular matrix, sarcomere shortening, mouse embryonic stem cells, disease modeling
MeSH terms
Calcium, Cell Differentiation, Extracellular Matrix, Laminin, Sarcomeres, Transcription, Genetic, Biomarkers, Gene Expression, Genes, Reporter, Computational Biology, Gene Expression Profiling, Myocytes, Cardiac, Pluripotent Stem Cells, Transcriptome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A Novel Fluorescent Reporter System Identifies Laminin-511/521 as Potent Regulators of Cardiomyocyte Maturation. https://app.cochat.ai/papers/10.1038/s41598-020-61163-3
The paper
Chanthra, N., Abe, T., Miyamoto, M., Sekiguchi, K., Kwon, C., Hanazono, Y., & Uosaki, H. (2020). A Novel Fluorescent Reporter System Identifies Laminin-511/521 as Potent Regulators of Cardiomyocyte Maturation. Scientific Reports. https://doi.org/10.1038/s41598-020-61163-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.